South Korea - Antiarrhythmic Medicine Use
Since 2014, South Korea Antiarrhythmic Medicine Use was up 7% year on year. In 2019, the country was ranked number 26 comparing other countries in Antiarrhythmic Medicine Use with 1.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Slovakia lead the ranking with 10.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +3.9% compared to 2018. Czech Republic, Belgium and Italy respectively ranked number 2, 3 and 4 in this ranking. South Korea witnessed the best average annual growth at +7% per year, while Chile recorded the worst performance at -4.1% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 1.40 |
| 2018 | 1.40 |
| 2017 | 1.30 |
| 2016 | 1.10 |
| 2015 | 1.10 |
Download all data from 2008 to 2019
How does South Korea rank in Antiarrhythmic Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Slovakia
|
11 | 2019 | +3.9 % | +1.4 % | View data | |
| 2 |
#2
Czech Republic
|
9 | 2019 | +2.3 % | +1.9 % | View data | |
| 24 |
#24
Denmark
|
2 | 2019 | +0.0 % | -1.3 % | View data | |
| 26 |
#26
South Korea
|
1 | 2019 | +0.0 % | +7.0 % | View data | |
| 27 |
#27
United Kingdom
|
1 | 2019 | +0.0 % | -3.0 % | View data | |